FINRA to review concentrations in high-risk structured notes

Madison Pacific Properties Inc. reports 1H results

2026/08/14

CASI Pharmaceuticals GAAP EPS of -$0.97, revenue of $9.8M

2026/08/14

Aileron Therapeutics reports Q2 results

2026/08/14

Fountain Asset reports Q2 results

2026/08/14